RATIONALE: There is evidence for a common genetic link between alcohol and nicotine dependence. Rodents selectively bred for high alcohol consumption/responsivity are also more likely to self-administer nicotine than controls. OBJECTIVES: The experiments examined the response to systemic nicotine, the effects of nicotine within the drug reward pathway, and innate expression of nicotine-related genes in a brain region regulating drug reward/self-administration in multiple lines of rats selectively bred for high and low alcohol consumption. METHODS: The experiments examined the effects of systemic administration of nicotine on locomotor activity, the effects of nicotine administered directly into the (posterior ventral tegmental area; pVTA) on dopamine (DA) release in the nucleus accumbens shell (AcbSh), and innate mRNA levels of acetylcholine receptor genes in the pVTA were determined in 6 selectively bred high/low alcohol consuming and Wistar rat lines. RESULTS: The high alcohol-consuming rat lines had greater nicotine-induced locomotor activity compared to low alcohol-consuming rat lines. Microinjections of nicotine into the pVTA resulted in DA release in the AcbSh with the dose response curves for high alcohol-consuming rats shifted leftward and upward. Genetic analysis of the pVTA indicated P rats expressed higher levels of α2 and β4. CONCLUSION: Selective breeding for high alcohol preference resulted in a genetically divergent behavioral and neurobiological sensitivity to nicotine. The observed behavioral and neurochemical differences between the rat lines would predict an increased likelihood of nicotine reinforcement. The data support the hypothesis of a common genetic basis for drug addiction and identifies potential receptor targets.
RATIONALE: There is evidence for a common genetic link between alcohol and nicotine dependence. Rodents selectively bred for high alcohol consumption/responsivity are also more likely to self-administer nicotine than controls. OBJECTIVES: The experiments examined the response to systemic nicotine, the effects of nicotine within the drug reward pathway, and innate expression of nicotine-related genes in a brain region regulating drug reward/self-administration in multiple lines of rats selectively bred for high and low alcohol consumption. METHODS: The experiments examined the effects of systemic administration of nicotine on locomotor activity, the effects of nicotine administered directly into the (posterior ventral tegmental area; pVTA) on dopamine (DA) release in the nucleus accumbens shell (AcbSh), and innate mRNA levels of acetylcholine receptor genes in the pVTA were determined in 6 selectively bred high/low alcohol consuming and Wistar rat lines. RESULTS: The high alcohol-consuming rat lines had greater nicotine-induced locomotor activity compared to low alcohol-consuming rat lines. Microinjections of nicotine into the pVTA resulted in DA release in the AcbSh with the dose response curves for high alcohol-consuming rats shifted leftward and upward. Genetic analysis of the pVTA indicated P rats expressed higher levels of α2 and β4. CONCLUSION: Selective breeding for high alcohol preference resulted in a genetically divergent behavioral and neurobiological sensitivity to nicotine. The observed behavioral and neurochemical differences between the rat lines would predict an increased likelihood of nicotine reinforcement. The data support the hypothesis of a common genetic basis for drug addiction and identifies potential receptor targets.
Entities:
Keywords:
Alcohol-preferring P rats; Dopamine; High-alcohol-drinking HAD rats; Locomotor activity; Nicotine; Nucleus accumbens; Ventral tegmental area
Authors: Kora-Mareen Bühler; Elena Giné; Victor Echeverry-Alzate; Javier Calleja-Conde; Fernando Rodriguez de Fonseca; Jose Antonio López-Moreno Journal: Addict Biol Date: 2015-01-21 Impact factor: 4.280
Authors: George R Uhl; Tomas Drgon; Catherine Johnson; Oluwatosin O Fatusin; Qing-Rong Liu; Carlo Contoreggi; Chuan-Yun Li; Kari Buck; John Crabbe Journal: Biochem Pharmacol Date: 2007-07-25 Impact factor: 5.858
Authors: Chella Kamarajan; Ashwini K Pandey; David B Chorlian; Niklas Manz; Arthur T Stimus; Lance O Bauer; Victor M Hesselbrock; Marc A Schuckit; Samuel Kuperman; John Kramer; Bernice Porjesz Journal: Int J Psychophysiol Date: 2015-09-18 Impact factor: 2.997
Authors: Sheketha R Hauser; Amy L Bracken; Gerald A Deehan; Jamie E Toalston; Zheng-Ming Ding; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd Journal: Addict Biol Date: 2013-03-18 Impact factor: 4.280
Authors: Gerald A Deehan; Sheketha R Hauser; R Aaron Waeiss; Christopher P Knight; Jamie E Toalston; William A Truitt; William J McBride; Zachary A Rodd Journal: Psychopharmacology (Berl) Date: 2015-08-26 Impact factor: 4.530
Authors: Robert A Waeiss; Christopher P Knight; Gustavo B Carvajal; Richard L Bell; Eric A Engleman; William J McBride; Sheketha R Hauser; Zachary A Rodd Journal: Behav Brain Res Date: 2019-08-29 Impact factor: 3.332
Authors: Sheketha R Hauser; Patrick J Mulholland; William A Truitt; R Aaron Waeiss; Eric A Engleman; Richard L Bell; Zachary A Rodd Journal: Int J Mol Sci Date: 2021-10-29 Impact factor: 5.923